Wednesday, August 09, 2023

Postpartum Depression’s New Treatment

Good news! Hopefully, other forms of depression can be better treated soon!

"The FDA’s approval late last week of the first pill targeting postpartum depression is a breakthrough in alleviating the widespread—yet under-treated—condition ...
The drug zuranolone, branded as Zurzuvae, is geared towards people with severe pregnancy-related depression and can relieve symptoms in just 3 days. It has previously been available only via IV.
The pills’ accessibility and speed are “extremely important” in the early days of parent-infant bonding ...
Under-treated: 
1 in 7 women experience depression after childbirth—but only half receive treatment ...
How the pills work: 
Taken 1X a day for 14 days, the drug mimics progesterone, a hormone that can plummet after childbirth.
A new study found that among 196 women with postpartum depression, 57% taking daily zuranolone showed “significant improvements” in symptoms after 2 weeks, which continued for 45 days."

Global Health NOW: Postpartum Depression’s New Treatment; Redefining Chronic Fatigue; and Solving Japan’s Recluse Problem

No comments: